Literature DB >> 23042996

New substrates on the block: clinically relevant resistances for EmrE and homologues.

Iris Nasie1, Sonia Steiner-Mordoch, Shimon Schuldiner.   

Abstract

Transporters of the small multidrug resistance (SMR) family are small homo- or heterodimers that confer resistance to multiple toxic compounds by exchanging substrate with protons. Despite the wealth of biochemical information on EmrE, the most studied SMR member, a high-resolution three-dimensional structure is missing. To provide proteins that are more amenable to biophysical and structural studies, we identified and partially characterized SMR transporters from bacteria living under extreme conditions of temperature and radiation. Interestingly, these homologues as well as EmrE confer resistance to streptomycin and tobramycin, two aminoglycoside antibiotics widely used in clinics. These are hydrophilic and clinically important substrates of SMRs, and study of their mode of action should contribute to understanding the mechanism of transport and to combating the phenomenon of multidrug resistance. Furthermore, our study of one of the homologues, a putative heterodimer, supports the suggestion that in the SMR family, heterodimers can also function as homodimers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042996      PMCID: PMC3510592          DOI: 10.1128/JB.01318-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  36 in total

1.  An essential glutamyl residue in EmrE, a multidrug antiporter from Escherichia coli.

Authors:  H Yerushalmi; S Schuldiner
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  A model for coupling of H(+) and substrate fluxes based on "time-sharing" of a common binding site.

Authors:  H Yerushalmi; S Schuldiner
Journal:  Biochemistry       Date:  2000-12-05       Impact factor: 3.162

Review 3.  A common binding site for substrates and protons in EmrE, an ion-coupled multidrug transporter.

Authors:  H Yerushalmi; S Schuldiner
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

Review 4.  Stability of membrane proteins: relevance for the selection of appropriate methods for high-resolution structure determinations.

Authors:  J P Rosenbusch
Journal:  J Struct Biol       Date:  2001-11       Impact factor: 2.867

Review 5.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 6.  SMR-type multidrug resistance pumps.

Authors:  Y J Chung; M H Saier
Journal:  Curr Opin Drug Discov Devel       Date:  2001-03

7.  A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE.

Authors:  T R Muth; S Schuldiner
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

8.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  Analysis of a complete library of putative drug transporter genes in Escherichia coli.

Authors:  K Nishino; A Yamaguchi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

10.  Functional analysis of novel multidrug transporters from human pathogens.

Authors:  S Ninio; D Rotem; S Schuldiner
Journal:  J Biol Chem       Date:  2001-09-26       Impact factor: 5.157

View more
  5 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Efflux by small multidrug resistance proteins is inhibited by membrane-interactive helix-stapled peptides.

Authors:  Kathrin Bellmann-Sickert; Tracy A Stone; Bradley E Poulsen; Charles M Deber
Journal:  J Biol Chem       Date:  2014-11-25       Impact factor: 5.157

Review 3.  Drug resistance: from bacteria to cancer.

Authors:  Harsh Patel; Zhuo-Xun Wu; Yanglu Chen; Letao Bo; Zhe-Sheng Chen
Journal:  Mol Biomed       Date:  2021-09-10

4.  Functional Role of YnfA, an Efflux Transporter in Resistance to Antimicrobial Agents in Shigella flexneri.

Authors:  Tanuka Sen; Naresh K Verma
Journal:  Antimicrob Agents Chemother       Date:  2022-06-21       Impact factor: 5.938

5.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.